Mark E. Josephson, former chief of cardiology at Beth Israel and Penn, dies at 73

Mark E. Josephson, MD, the emeritus chief of cardiology at Beth Israel Deaconess Medical Center in Boston, died from cancer earlier this year, the Boston Globe reports. He was 73.

During his career, Josephson trained more the 200 electrophysiologists. The newspaper also noted that Josephson diagnosed former Boston Celtics guard Reggie Lewis with a life-threatening arrhythmia shortly before Lewis died in 1993. Josephson was involved in two trials following Lewis’s death and testified about his earlier diagnosis.

After graduating from medical school and completing his residency, Josephson began conducting electrophysiology research at the US Public Health Service’s hospital in Staten Island, New York. He later joined the Penn faculty in 1975 and was named the chief of cardiology at the University of Pennsylvania at age 38.

Josephson joined Beth Israel in 1992 and served as chief of cardiovascular medicine from 2001 until his retirement in 2015.

Read the full article below:

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.